This research report provides a comprehensive analysis of the Infectious Disease Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Infectious Disease Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Infectious Disease Drugs, challenges faced by the industry, and potential opportunities for market players.
The global Infectious Disease Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Infectious Disease Drugs market presents opportunities for various stakeholders, including HIV, Malaria. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Infectious Disease Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The global Infectious Disease Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Infectious Disease Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Infectious Disease Drugs market.
Market Overview: The report provides a comprehensive overview of the Infectious Disease Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Antibacterials, Antiviral drugs), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Infectious Disease Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Infectious Disease Drugs market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Infectious Disease Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Infectious Disease Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Infectious Disease Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Infectious Disease Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Infectious Disease Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Infectious Disease Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Infectious Disease Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Antibacterials
Antiviral drugs
Antiparasitic drugs
Antifungal
Others
Market segment by Application
HIV
Malaria
Hepatitis
Influenza
HPV
Tuberculosis
Others
Global Infectious Disease Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
GlaxoSmithKline
Gilead Sciences
Merck & Co.
Pfizer
Sanofi
AbbVie
Shire
Grifols
Johnson & Johnson
Protein Sciences
AstraZeneca
Outline of Major Chapters:
Chapter 1: Introduces the definition of Infectious Disease Drugs, market overview.
Chapter 2: Global Infectious Disease Drugs market size in revenue.
Chapter 3: Detailed analysis of Infectious Disease Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Infectious Disease Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Infectious Disease Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Infectious Disease Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Infectious Disease Drugs Overall Market Size
2.1 Global Infectious Disease Drugs Market Size: 2023 VS 2030
2.2 Global Infectious Disease Drugs Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Infectious Disease Drugs Players in Global Market
3.2 Top Global Infectious Disease Drugs Companies Ranked by Revenue
3.3 Global Infectious Disease Drugs Revenue by Companies
3.4 Top 3 and Top 5 Infectious Disease Drugs Companies in Global Market, by Revenue in 2023
3.5 Global Companies Infectious Disease Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Infectious Disease Drugs Players in Global Market
3.6.1 List of Global Tier 1 Infectious Disease Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Infectious Disease Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Infectious Disease Drugs Market Size Markets, 2023 & 2030
4.1.2 Antibacterials
4.1.3 Antiviral drugs
4.1.4 Antiparasitic drugs
4.1.5 Antifungal
4.1.6 Others
4.2 By Type - Global Infectious Disease Drugs Revenue & Forecasts
4.2.1 By Type - Global Infectious Disease Drugs Revenue, 2019-2024
4.2.2 By Type - Global Infectious Disease Drugs Revenue, 2025-2030
4.2.3 By Type - Global Infectious Disease Drugs Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Infectious Disease Drugs Market Size, 2023 & 2030
5.1.2 HIV
5.1.3 Malaria
5.1.4 Hepatitis
5.1.5 Influenza
5.1.6 HPV
5.1.7 Tuberculosis
5.1.8 Others
5.2 By Application - Global Infectious Disease Drugs Revenue & Forecasts
5.2.1 By Application - Global Infectious Disease Drugs Revenue, 2019-2024
5.2.2 By Application - Global Infectious Disease Drugs Revenue, 2025-2030
5.2.3 By Application - Global Infectious Disease Drugs Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Infectious Disease Drugs Market Size, 2023 & 2030
6.2 By Region - Global Infectious Disease Drugs Revenue & Forecasts
6.2.1 By Region - Global Infectious Disease Drugs Revenue, 2019-2024
6.2.2 By Region - Global Infectious Disease Drugs Revenue, 2025-2030
6.2.3 By Region - Global Infectious Disease Drugs Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Infectious Disease Drugs Revenue, 2019-2030
6.3.2 US Infectious Disease Drugs Market Size, 2019-2030
6.3.3 Canada Infectious Disease Drugs Market Size, 2019-2030
6.3.4 Mexico Infectious Disease Drugs Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Infectious Disease Drugs Revenue, 2019-2030
6.4.2 Germany Infectious Disease Drugs Market Size, 2019-2030
6.4.3 France Infectious Disease Drugs Market Size, 2019-2030
6.4.4 U.K. Infectious Disease Drugs Market Size, 2019-2030
6.4.5 Italy Infectious Disease Drugs Market Size, 2019-2030
6.4.6 Russia Infectious Disease Drugs Market Size, 2019-2030
6.4.7 Nordic Countries Infectious Disease Drugs Market Size, 2019-2030
6.4.8 Benelux Infectious Disease Drugs Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Infectious Disease Drugs Revenue, 2019-2030
6.5.2 China Infectious Disease Drugs Market Size, 2019-2030
6.5.3 Japan Infectious Disease Drugs Market Size, 2019-2030
6.5.4 South Korea Infectious Disease Drugs Market Size, 2019-2030
6.5.5 Southeast Asia Infectious Disease Drugs Market Size, 2019-2030
6.5.6 India Infectious Disease Drugs Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Infectious Disease Drugs Revenue, 2019-2030
6.6.2 Brazil Infectious Disease Drugs Market Size, 2019-2030
6.6.3 Argentina Infectious Disease Drugs Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Infectious Disease Drugs Revenue, 2019-2030
6.7.2 Turkey Infectious Disease Drugs Market Size, 2019-2030
6.7.3 Israel Infectious Disease Drugs Market Size, 2019-2030
6.7.4 Saudi Arabia Infectious Disease Drugs Market Size, 2019-2030
6.7.5 UAE Infectious Disease Drugs Market Size, 2019-2030
7 Infectious Disease Drugs Companies Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Infectious Disease Drugs Major Product Offerings
7.1.4 GlaxoSmithKline Infectious Disease Drugs Revenue in Global Market (2019-2024)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Company Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences Infectious Disease Drugs Major Product Offerings
7.2.4 Gilead Sciences Infectious Disease Drugs Revenue in Global Market (2019-2024)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 Merck & Co.
7.3.1 Merck & Co. Company Summary
7.3.2 Merck & Co. Business Overview
7.3.3 Merck & Co. Infectious Disease Drugs Major Product Offerings
7.3.4 Merck & Co. Infectious Disease Drugs Revenue in Global Market (2019-2024)
7.3.5 Merck & Co. Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Infectious Disease Drugs Major Product Offerings
7.4.4 Pfizer Infectious Disease Drugs Revenue in Global Market (2019-2024)
7.4.5 Pfizer Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Infectious Disease Drugs Major Product Offerings
7.5.4 Sanofi Infectious Disease Drugs Revenue in Global Market (2019-2024)
7.5.5 Sanofi Key News & Latest Developments
7.6 AbbVie
7.6.1 AbbVie Company Summary
7.6.2 AbbVie Business Overview
7.6.3 AbbVie Infectious Disease Drugs Major Product Offerings
7.6.4 AbbVie Infectious Disease Drugs Revenue in Global Market (2019-2024)
7.6.5 AbbVie Key News & Latest Developments
7.7 Shire
7.7.1 Shire Company Summary
7.7.2 Shire Business Overview
7.7.3 Shire Infectious Disease Drugs Major Product Offerings
7.7.4 Shire Infectious Disease Drugs Revenue in Global Market (2019-2024)
7.7.5 Shire Key News & Latest Developments
7.8 Grifols
7.8.1 Grifols Company Summary
7.8.2 Grifols Business Overview
7.8.3 Grifols Infectious Disease Drugs Major Product Offerings
7.8.4 Grifols Infectious Disease Drugs Revenue in Global Market (2019-2024)
7.8.5 Grifols Key News & Latest Developments
7.9 Johnson & Johnson
7.9.1 Johnson & Johnson Company Summary
7.9.2 Johnson & Johnson Business Overview
7.9.3 Johnson & Johnson Infectious Disease Drugs Major Product Offerings
7.9.4 Johnson & Johnson Infectious Disease Drugs Revenue in Global Market (2019-2024)
7.9.5 Johnson & Johnson Key News & Latest Developments
7.10 Protein Sciences
7.10.1 Protein Sciences Company Summary
7.10.2 Protein Sciences Business Overview
7.10.3 Protein Sciences Infectious Disease Drugs Major Product Offerings
7.10.4 Protein Sciences Infectious Disease Drugs Revenue in Global Market (2019-2024)
7.10.5 Protein Sciences Key News & Latest Developments
7.11 AstraZeneca
7.11.1 AstraZeneca Company Summary
7.11.2 AstraZeneca Business Overview
7.11.3 AstraZeneca Infectious Disease Drugs Major Product Offerings
7.11.4 AstraZeneca Infectious Disease Drugs Revenue in Global Market (2019-2024)
7.11.5 AstraZeneca Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Infectious Disease Drugs Market Opportunities & Trends in Global Market
Table 2. Infectious Disease Drugs Market Drivers in Global Market
Table 3. Infectious Disease Drugs Market Restraints in Global Market
Table 4. Key Players of Infectious Disease Drugs in Global Market
Table 5. Top Infectious Disease Drugs Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Infectious Disease Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Infectious Disease Drugs Revenue Share by Companies, 2019-2024
Table 8. Global Companies Infectious Disease Drugs Product Type
Table 9. List of Global Tier 1 Infectious Disease Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Infectious Disease Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Infectious Disease Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Infectious Disease Drugs Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Infectious Disease Drugs Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Infectious Disease Drugs Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Infectious Disease Drugs Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Infectious Disease Drugs Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Infectious Disease Drugs Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Infectious Disease Drugs Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Infectious Disease Drugs Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Infectious Disease Drugs Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Infectious Disease Drugs Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Infectious Disease Drugs Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Infectious Disease Drugs Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Infectious Disease Drugs Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Infectious Disease Drugs Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Infectious Disease Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Infectious Disease Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Infectious Disease Drugs Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Infectious Disease Drugs Revenue, (US$, Mn), 2025-2030
Table 30. GlaxoSmithKline Company Summary
Table 31. GlaxoSmithKline Infectious Disease Drugs Product Offerings
Table 32. GlaxoSmithKline Infectious Disease Drugs Revenue (US$, Mn) & (2019-2024)
Table 33. GlaxoSmithKline Key News & Latest Developments
Table 34. Gilead Sciences Company Summary
Table 35. Gilead Sciences Infectious Disease Drugs Product Offerings
Table 36. Gilead Sciences Infectious Disease Drugs Revenue (US$, Mn) & (2019-2024)
Table 37. Gilead Sciences Key News & Latest Developments
Table 38. Merck & Co. Company Summary
Table 39. Merck & Co. Infectious Disease Drugs Product Offerings
Table 40. Merck & Co. Infectious Disease Drugs Revenue (US$, Mn) & (2019-2024)
Table 41. Merck & Co. Key News & Latest Developments
Table 42. Pfizer Company Summary
Table 43. Pfizer Infectious Disease Drugs Product Offerings
Table 44. Pfizer Infectious Disease Drugs Revenue (US$, Mn) & (2019-2024)
Table 45. Pfizer Key News & Latest Developments
Table 46. Sanofi Company Summary
Table 47. Sanofi Infectious Disease Drugs Product Offerings
Table 48. Sanofi Infectious Disease Drugs Revenue (US$, Mn) & (2019-2024)
Table 49. Sanofi Key News & Latest Developments
Table 50. AbbVie Company Summary
Table 51. AbbVie Infectious Disease Drugs Product Offerings
Table 52. AbbVie Infectious Disease Drugs Revenue (US$, Mn) & (2019-2024)
Table 53. AbbVie Key News & Latest Developments
Table 54. Shire Company Summary
Table 55. Shire Infectious Disease Drugs Product Offerings
Table 56. Shire Infectious Disease Drugs Revenue (US$, Mn) & (2019-2024)
Table 57. Shire Key News & Latest Developments
Table 58. Grifols Company Summary
Table 59. Grifols Infectious Disease Drugs Product Offerings
Table 60. Grifols Infectious Disease Drugs Revenue (US$, Mn) & (2019-2024)
Table 61. Grifols Key News & Latest Developments
Table 62. Johnson & Johnson Company Summary
Table 63. Johnson & Johnson Infectious Disease Drugs Product Offerings
Table 64. Johnson & Johnson Infectious Disease Drugs Revenue (US$, Mn) & (2019-2024)
Table 65. Johnson & Johnson Key News & Latest Developments
Table 66. Protein Sciences Company Summary
Table 67. Protein Sciences Infectious Disease Drugs Product Offerings
Table 68. Protein Sciences Infectious Disease Drugs Revenue (US$, Mn) & (2019-2024)
Table 69. Protein Sciences Key News & Latest Developments
Table 70. AstraZeneca Company Summary
Table 71. AstraZeneca Infectious Disease Drugs Product Offerings
Table 72. AstraZeneca Infectious Disease Drugs Revenue (US$, Mn) & (2019-2024)
Table 73. AstraZeneca Key News & Latest Developments
List of Figures
Figure 1. Infectious Disease Drugs Segment by Type in 2023
Figure 2. Infectious Disease Drugs Segment by Application in 2023
Figure 3. Global Infectious Disease Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Infectious Disease Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Infectious Disease Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Infectious Disease Drugs Revenue in 2023
Figure 8. By Type - Global Infectious Disease Drugs Revenue Market Share, 2019-2030
Figure 9. By Application - Global Infectious Disease Drugs Revenue Market Share, 2019-2030
Figure 10. By Type - Global Infectious Disease Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Infectious Disease Drugs Revenue Market Share, 2019-2030
Figure 12. By Application - Global Infectious Disease Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Infectious Disease Drugs Revenue Market Share, 2019-2030
Figure 14. By Region - Global Infectious Disease Drugs Revenue Market Share, 2019-2030
Figure 15. By Country - North America Infectious Disease Drugs Revenue Market Share, 2019-2030
Figure 16. US Infectious Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Infectious Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Infectious Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Infectious Disease Drugs Revenue Market Share, 2019-2030
Figure 20. Germany Infectious Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 21. France Infectious Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Infectious Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Infectious Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Infectious Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Infectious Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Infectious Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Infectious Disease Drugs Revenue Market Share, 2019-2030
Figure 28. China Infectious Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Infectious Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Infectious Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Infectious Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. India Infectious Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Infectious Disease Drugs Revenue Market Share, 2019-2030
Figure 34. Brazil Infectious Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Infectious Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Infectious Disease Drugs Revenue Market Share, 2019-2030
Figure 37. Turkey Infectious Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Infectious Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Infectious Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Infectious Disease Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. GlaxoSmithKline Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Gilead Sciences Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Merck & Co. Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Pfizer Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Sanofi Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. AbbVie Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Shire Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Grifols Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Johnson & Johnson Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Protein Sciences Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. AstraZeneca Infectious Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
